.Merck beats incomes assumptions, brings up purchases outlook on sturdy requirement for leading medicines like Keytruda CNBCMerck & Co. (MRK United States) Trumps Income Projections as Keytruda Purchases Surge BloombergMerck Inventory: Pharma Titan Posts Powerful End Results, Yet Expectation Falls Short Entrepreneur's Business DailyMerck Announces Second-Quarter 2024 Financial End results Yahoo FinanceMerck beats profit as well as purchases desires amid Keytruda advantage, but delivers combined full-year outlook MarketWatch.